IRIX Common Stock · Transaction Oct 2, 2023 · Filed Nov 8, 2023 · Amount pending receipt enrichment
IRIDEX Corp
Veridion Score
BETALOW CONF · 5/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is IRIX moving today?
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
IRIX overview
Related filings and maps
Congress activity in IRIX
IRIX contract awards, year to date.
Public federal awards linked to this ticker.
IRIX lobbying filings, year to date.
Registered lobbying filings matched to IRIDEX Corp.